HBcrAg-话题@MedSci - 梅斯（MedSci）

#HBcrAg#

0篇内容 | 791人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2243275, encodeId=119d22432e550, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【AASLD2024速递】慢乙肝临床治愈持久性相关因素探索：循环CCR7(LO)PD-1(HI)滤泡辅助T细胞和HBcrAg水平, objectType=article, longId=851389, objectId=fd3985138939, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716173655527_5579292.jpg, objectUrl=/article/show_article.do?id=fd3985138939, replyNumber=0, likeNumber=7, createdTime=2024-12-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fd3985138939, moduleTitle=【AASLD2024速递】慢乙肝临床治愈持久性相关因素探索：循环CCR7(LO)PD-1(HI)滤泡辅助T细胞和HBcrAg水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fd3985138939)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190994, encodeId=734d219099406, content=<a href='/topic/show?id=2d305285e9f' target=_blank style='color:#2F92EE;'>#恩替卡韦#</a> <a href='/topic/show?id=b41a603616e' target=_blank style='color:#2F92EE;'>#替诺福韦酯#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测, objectType=article, longId=815455, objectId=bee481545527, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=bee481545527, replyNumber=0, likeNumber=66, createdTime=2024-03-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bee481545527, moduleTitle=【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bee481545527)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

HBcrAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #HBcrAg#

【AASLD2024速递】慢乙肝临床治愈持久性相关因素探索：循环CCR7(LO)PD-1(HI)滤泡辅助T细胞和HBcrAg水平

2024-12-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#恩替卡韦# #替诺福韦酯# #慢乙肝# #HBcrAg#

【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测

2024-03-04发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务